Abstracts
Melanoma and other skin tumours
1220PD - Phase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma

https://doi.org/10.1093/annonc/mdx377.007Get rights and content
Under an Elsevier user license
open archive

Cited by (0)